Learning Objectives & Target Audience
At the conclusion of the 2016 ACMG Annual Meeting, participants should be able to:
- Describe the latest advanced in the field of Cancer Genomics
- Distinguish advantages and disadvantages between various methodologies for optimal patient care.
- Describe rare known genetic conditions diagnosed on prenatal ultrasound
- Assist in the differential diagnoses of unknown cases.
- Recognize cardinal clinical signs and symptoms of specific rare syndromic conditions.
- identify the appropriate molecular diagnostic testing strategies.
- Review the application and significance of variants found on molecular results.
- Describe the clinical manifestations of neurogenetic diseases.
- Identify available genetic testing, screening, prevention and treatment options for neurogenetic diseases
- Describe components of the ABMGG Certification and Maintenance of Certification.
- Describe the issues surrounding newborn screening for lysosomal storage disorders.
- Critically assess the value of pharmacogenetics information in patient.
All healthcare professionals interested in the diagnosis, management, treatment and prevention of genetic conditions and increasing their understanding of the genetic basis of common, chronic health problems affecting both children and adults will find the programming applicable to their practice. The ACMG Annual Meeting attendees include:
- Medical and clinical geneticists
- Physicians of all specialties with an interest in genetics, genomics and the genetic basis of disease
- Genetic counselors
- Laboratory geneticists, directors, technicians and technologists
- Physician assistants
- Biotechnology and pharmaceutical development professionals
- Fellows, Trainees and Students
- Public health professionals
- Genetic/consumer advocates
- Others with an interest in the science and art of medical genetics and genomics